These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37963051)

  • 1. Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.
    Rand LZ; Carpenter DP; Kesselheim AS; Bhaskar A; Darrow JJ; Feldman WB
    Hastings Cent Rep; 2023 Sep; 53 Suppl 2():S60-S68. PubMed ID: 37963051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process.
    Patel NG; Kesselheim AS; Darrow JJ
    J Health Polit Policy Law; 2023 Oct; 48(5):799-820. PubMed ID: 36995365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018.
    Janiaud P; Irony T; Russek-Cohen E; Goodman SN
    Ann Intern Med; 2021 Nov; 174(11):1603-1611. PubMed ID: 34543584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.
    Daval CJR; Teng TW; Russo M; Kesselheim AS
    JAMA Health Forum; 2023 Jul; 4(7):e231718. PubMed ID: 37418270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shattering the Mirage: The FDA's Early COVID-19 Pandemic Response Demonstrates a Need for Reform to Restore Agency Credibility.
    Fuleihan C
    Am J Law Med; 2022 Dec; 48(4):307-342. PubMed ID: 37039751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.
    Schmidt AM; Jarman KL; Ranney LM; Queen TL; Noar SM; Ruel L; Agans R; Hannan A; Goldstein AO
    Nicotine Tob Res; 2018 Sep; 20(11):1310-1316. PubMed ID: 29059369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trust in the Food and Drug Administration: A National Survey Study.
    Feldman WB; Rand LZ; Carpenter D; Russo M; Bhaskar A; Lu Z; Campbell EG; Darrow J; Kesselheim AS
    Clin Pharmacol Ther; 2024 Aug; 116(2):408-414. PubMed ID: 38757305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional Steps for Maintaining Public Trust in the FDA.
    Berger M
    Hastings Cent Rep; 2024 Mar; 54(2):44. PubMed ID: 38639165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System.
    Weitzman ER; Sherman AC; Levy O
    Front Public Health; 2021; 9():695807. PubMed ID: 34336774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The US Food and drug administration: drug information resource for formulary recommendations.
    Marchand HC; Ros BJ; Fine AM; Kremzner ME
    J Manag Care Pharm; 2012; 18(9):713-8. PubMed ID: 23206214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: opportunities for public health ethics?
    Maeckelberghe E
    J R Coll Physicians Edinb; 2021 Jun; 51(S1):S47-S52. PubMed ID: 34185038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of Vaccine Licensure, Approval, and Recommendations for Use.
    Pickering LK; Meissner HC; Orenstein WA; Cohn AC
    Mayo Clin Proc; 2020 Mar; 95(3):600-608. PubMed ID: 32063358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.
    Kesselheim AS; Eddings W; Raj T; Campbell EG; Franklin JM; Ross KM; Fulchino LA; Avorn J; Gagne JJ
    PLoS One; 2016; 11(10):e0163339. PubMed ID: 27768700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Political Ideology and Trust in Government to Ensure Vaccine Safety: Using a U.S. Survey to Explore the Role of Political Trust.
    Lim J; Moon KK
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants.
    Chahal HS; Mukherjee S; Sigelman DW; Temple R
    JAMA Intern Med; 2021 Apr; 181(4):522-529. PubMed ID: 33587091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public trust is earned: Historical discrimination, carceral violence, and the COVID-19 pandemic.
    Anderson A; Lewis DF; Shafer P; Anderson J; LaVeist TA
    Health Serv Res; 2023 Aug; 58 Suppl 2(Suppl 2):218-228. PubMed ID: 37279782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help.
    Waxman H; Corr B; Martin K; Duong S
    Issue Brief (Commonw Fund); 2018 Apr; 2018():1-10. PubMed ID: 29992802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the vaccine confidence gap.
    Larson HJ; Cooper LZ; Eskola J; Katz SL; Ratzan S
    Lancet; 2011 Aug; 378(9790):526-35. PubMed ID: 21664679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.